In silico analysis of four CYP2C19 genetic variants categorized them into metabolic phenotypes to predict their impact on the metabolism and safety of drugs like Clopidogrel.
Does in silico analysis of CYP2C19 genetic variants predict their functional impact on the metabolism of drugs like clopidogrel?
In silico analysis of CYP2C19 variants can predict metabolic phenotypes, potentially improving personalized medicine and safety for drugs like clopidogrel.
Absolute Event Rate: 0% vs 0%
This study provides an in silico analysis of four CYP2C19 genetic variants—rs3758581, rs113994117, rs12248560, and rs28399504—to predict their functional impact on drug metabolism. Using SIFT and PolyPhen-2, the research categorizes these mutations into metabolic phenotypes to improve personalized medicine and safety for drugs like Clopidogrel.
Aakriti Kaushal (Sun,) reported a other. In silico analysis of four CYP2C19 genetic variants categorized them into metabolic phenotypes to predict their impact on the metabolism and safety of drugs like Clopidogrel.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: